Guardian Pharmacy Services, Inc. GRDN
41.21
(0.58)
(1.39%)
as of 25 Sep
- Market cap
- $2.7B
- P/E
- 39.2×
Follow GRDN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+7 more TTM periods Free account |
24.43% | 26.76% | 26.83% | 30.14% | |
| 10.90% | 13.42% | 13.95% | 16.48% | ||
ROIC |
23.07% | 29.83% | 28.86% | 31.82% | |
Return on Tangible Assets |
43.53% | 42.27% | 40.43% | 41.94% | |
Average Days of Receivables |
27.89 | 25.60 | 28.00 | 25.88 | |
Free Cash Flow per Share |
1.10 | 1.29 | 1.11 | 1.26 | |
Free Cash Flow |
68.17 | 80.71 | 70.28 | 79.79 | |
Capital Expenditures |
(19.82) | (19.54) | (18.49) | (19.07) | |
Piotroski F-Score |
1.00 | 6.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
37.93% | 35.36% | 29.86% | 28.45% | |
Accounts Receivable Turnover |
14.10 | 14.58 | 13.93 | 14.79 | |
Accounts Payable Turnover |
9.76 | 10.57 | 10.95 | 10.76 | |
Inventory Turnover |
23.97 | 27.55 | 25.42 | 24.25 | |
Average Days of Payables |
39.82 | 36.69 | 34.41 | 34.44 | |
Days of Inventory on Hand |
15.66 | 13.69 | 14.95 | 16.05 | |
Tax Rate |
(0.32) | (0.33) | (0.32) | (0.31) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
15.52% | 15.19% | 15.61% | 15.79% | |
Share Based Compensation of Revenue |
1.17% | 0.96% | 0.81% | 0.70% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.19 | 2.04 | 1.67 | 1.50 | |
Depreciation/Fixed assets |
0.39 | 0.40 | 0.41 | 0.41 | |
Capex/Depreciation |
(0.91) | (0.88) | (0.80) | (0.82) | |
Revenue per Share |
22.37 | 23.22 | 22.99 | 23.11 | |
Operating CF per Share |
1.42 | 1.61 | 1.40 | 1.56 | |
Capex per Share |
(0.32) | (0.31) | (0.29) | (0.30) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
2.90% | 3.40% | 3.64% | 4.50% |
Columns are period end dates